Quidel | QDEL - Gross Profit On Sales



Quidel reported $227M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Abbott USD 5.87B 50M Jun/2025
Agilent USD 888M 22M Jul/2025
Avanos Medical USD 92.1M 2.3M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Bruker USD 357.9M 33.3M Jun/2025
Charles River Laboratories USD 291.68M 48.42M Jun/2025
Danaher USD 3.52B 3M Jun/2025
Exact Sciences USD 562.45M 61.91M Jun/2025
Haemonetics USD 192.24M 806K Jun/2025
Hologic USD 576.6M 15.9M Jun/2025
Illumina USD 695M 12M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Mettler Toledo International USD 579.88M 54M Jun/2025
Myriad Genetics USD 134.2M 16.7M Mar/2025
Neogen USD 92.85M 17.41M May/2025
Quidel USD 227M 116.3M Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
STAAR Surgical USD 32.8M 4.79M Jun/2025
Thermo Fisher Scientific USD 4.05B 260M Jun/2025
Waters USD 438.02M 53.06M Jun/2025